Dr. Yong P. Tang

Dr. Solmaz Sahebjam is a medical oncologist and an associate professor of oncology at Johns Hopkins University School of Medicine. Her expertise is in primary and metastatic brain tumors, breast cancer, and the development of new drugs for cancer. She earned her medical degree from Iran University of Medical Sciences, followed by a post-doctoral research fellowship at Shriners Hospital, McGill University in Montreal. Dr. Sahebjam completed residency training in internal medicine at Saint Vincent Hospital, followed by a fellowship in internal medicine at the University of Ottawa in Canada. She continued her training with a residency in medical oncology at McGill University in Canada followed by a fellowship in early-phase drug development, breast oncology, and neurooncology at Princess Margaret Hospital, University of Toronto in Canada. Dr. Sahebjam’s research is focused on the development of novel therapeutic regimens for the treatment of cancer including breast and central nervous system malignancies. Over the years, she has led and contributed to numerous clinical trials some of which have resulted in new treatment options for patients with cancer. Dr. Sahebjam is rated as an Elite provider by MediFind in the treatment of Medulloblastoma. Her top areas of expertise are Glioma, Brain Tumor, Glioblastoma, Astrocytoma, and Awake Craniotomy.

Edward Sausville is an Oncologist in Baltimore, Maryland. Dr. Sausville is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Astrocytoma, Embryonal Tumor with Multilayered Rosettes, Glioblastoma, Neuroepithelioma, and Bone Marrow Aspiration.

Pooja Sahni is a Hematologist Oncology specialist and a Hematologist in Chambersburg, Pennsylvania. Dr. Sahni is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. Her top areas of expertise are Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Sahni is currently accepting new patients.